Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study. [electronic resource]
Producer: 20130314Description: 2008-11 p. digitalISSN:- 1499-2752
- Adult
- Antirheumatic Agents -- therapeutic use
- Azathioprine -- therapeutic use
- Female
- Humans
- Interleukin 1 Receptor Antagonist Protein -- therapeutic use
- Isoxazoles -- therapeutic use
- Leflunomide
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Receptors, Interleukin-1 -- antagonists & inhibitors
- Remission Induction
- Still's Disease, Adult-Onset -- drug therapy
- Sulfasalazine -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.